TrialJournal of cancer research and clinical oncology2022

A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab.

Matthew Hummel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.